Home/Recalls/CANADA-74317
Health CanadaType I

ATROPINE SULFATE INJECTION USP: Affected lot may contain the presence of glass ...

Published: September 20, 2023Recall ID: 74317Category: generalCountry: Canada

Reason for Recall / Hazard

Product quality

Product Description & Identification

Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.Contact the recalling firm if you have any questions about the recall.Report any health product related side effects to Health Canada.Report any other health product safety complaints to Health Canada.

Affected Products

ATROPINE SULFATE INJECTION USP (10ML PREFILLED SYRINGE)

Additional Source Details

FieldValue
N I D74317
U R Lhttps://recalls-rappels.canada.ca/en/alert-recall/atropine-sulfate-injection-usp-affected-lot-may-contain-presence-glass-particulate
IssueProduct quality
TitleATROPINE SULFATE INJECTION USP: Affected lot may contain the presence of glass particulate.
ProductATROPINE SULFATE INJECTION USP (10ML PREFILLED SYRINGE)
Archived0
CategoryDrugs
Last updated2023-09-20
OrganizationDrugs and health products
Recall classType I
What you should doVerify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.Contact the recalling firm if you have any questions about the recall.Report any health product related side effects to Health Canada.Report any other health product safety complaints to Health Canada.

Overview

  • Recalling FirmDrugs and health products
  • Risk LevelType I
Official Agency Alert